2022
DOI: 10.1007/s00415-022-10980-9
|View full text |Cite
|
Sign up to set email alerts
|

The efficacy of speed of processing training for improving processing speed in individuals with multiple sclerosis: a randomized clinical trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 48 publications
0
2
0
Order By: Relevance
“…FDA-approved dementia medications donepezil and memantine failed to reduce cognitive dysfunction in MS trials [4,5]. The popular supplements gingko biloba and vitamin D similarly failed in clinical trials for that purpose [6,7]. Cognitive behavioral therapy can improve processing speed dysfunction in people with MS, but suffers from limited access due to factors like proximity to services, health insurance coverage, and time required to participate [8].…”
Section: Introductionmentioning
confidence: 99%
“…FDA-approved dementia medications donepezil and memantine failed to reduce cognitive dysfunction in MS trials [4,5]. The popular supplements gingko biloba and vitamin D similarly failed in clinical trials for that purpose [6,7]. Cognitive behavioral therapy can improve processing speed dysfunction in people with MS, but suffers from limited access due to factors like proximity to services, health insurance coverage, and time required to participate [8].…”
Section: Introductionmentioning
confidence: 99%
“…FDA-approved dementia medications donepezil and 2 memantine failed to reduce cognitive dysfunction in MS trials [4,5]. Cognitive behavioral therapy can improve processing speed dysfunction in people with MS, but suffers from limited access [6].…”
Section: Introductionmentioning
confidence: 99%